Daubry Alison

Main Referenced Co-authors

Bougard, Marine (3)

BURTEA, Carmen (3)

KAHVECIOGLU, Zehra Cagla (3)

LAURENT, Sophie (3)

SAUSSEZ, Sven (3)

Main Referenced Keywords

apoptosis (3); EGFR (2); therapeutic peptide (2); anaplastic thyroïde cancer (1); EGFR targeting (1);

Main Referenced Unit & Research Centers

CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (3)

Main Referenced Disciplines

Oncology (2)

Anatomy (cytology, histology, embryology...) & physiology (1)

Biochemistry, biophysics & molecular biology (1)

Publications (total 3)

Search in publications

The most downloaded

12 downloads

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Sarah Peeters, Daubry, A., Laurent, S., Saussez, S., & Burtea, C. (06 February 2024). Toward the development of a novel drug using engineered peptides designed for EGFR-mediated drug delivery of an apoptosis inducer in anaplastic thyroid carcinoma [Paper presentation]. Télévie Seminar. https://hdl.handle.net/20.500.12907/48533

https://hdl.handle.net/20.500.12907/48533

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (24 November 2023). Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment [Poster presentation]. PhD Day SFMBBM 2023, Liège, Belgium.

https://hdl.handle.net/20.500.12907/46851

Peer reviewed

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Rogien, C., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (27 October 2023). Novel therapeutic approaches for EGFR-mediated drug delivery using engineered peptides in anaplastic thyroid cancer [Poster presentation]. Annual BACR Meeting 2023 Friday October 27th, CIRCADIAN CYCLE, CHRONOBIOLOGY AND CANCER, brussels, Belgium.

https://hdl.handle.net/20.500.12907/46914

Peer reviewed